Mifepristone 25mg Tablet PCD Pharma Franchise Delhi

Mifepristone 25mg Tablet Manufacturing Company Baddi

Mifepristone 25mg Tablet Gynaecology Franchise Pune

Mifepristone 25mg Tablet Pharma Supplier Mumbai

Mifepristone 25mg Tablet Export Company Chennai
Mifepristone 25mg Tablet Franchise Opportunity Hyd

Home/Products /mifepristone-25mg-tablet

About the Product

Description


Fibromiss 25 Tablet contains Mifepristone, a selective progesterone receptor modulator (SPRM) that exerts anti-progestational effects by competitively binding to progesterone receptors. At the 25 mg dose, Mifepristone is primarily used for the medical management of uterine fibroids to reduce their size, alleviate symptoms like heavy menstrual bleeding, pelvic pain, and pressure symptoms, and help improve quality of life in women with symptomatic leiomyomas. Mifepristone works by blocking progesterone’s action on uterine tissue, leading to shrinkage of fibroids and endometrial thinning. Unlike the high-dose Mifepristone used in medical termination of pregnancy, Fibromiss 25 Tablet is designed for long-term, low-dose therapy with a favorable safety profile.

Common side effects include mild nausea, headache, abdominal pain, fatigue, and hot flashes. Menstrual irregularities or amenorrhea (absence of periods) can occur during treatment due to the hormonal action. Less commonly, endometrial changes, reversible liver enzyme elevations, or mild weight gain may be observed. Rare adverse effects include hypersensitivity reactions and significant endometrial thickening with prolonged unsupervised use.

Fibromiss 25 Tablet is indicated for the treatment of uterine fibroids (leiomyomas) in premenopausal women, particularly in cases with menorrhagia (heavy bleeding), dysmenorrhea, or pelvic discomfort. It may also be used in certain gynecological conditions under specialist supervision.

Fibromiss 25 Tablet should be used strictly under the supervision of a gynecologist. It is not intended for pregnancy termination at this dose and must not be used in pregnant women, as it can harm the fetus. Regular ultrasound monitoring of fibroid size and endometrial thickness is recommended during therapy. Caution is advised in patients with liver disorders, bleeding abnormalities, or long-term unopposed estrogen therapy. It should not be used by women seeking conception during treatment. Once the medication is stopped, normal menstruation usually resumes within a few months. Alcohol and self-medication should be avoided, and any unusual bleeding or severe abdominal pain should be reported to the physician immediately.

Store Fibromiss 25 Tablet in a cool, dry place below 30°C, away from direct sunlight and moisture. Keep the tablets in their original packaging and out of reach of children. Do not use beyond the expiry date mentioned on the pack.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions

What are the business opportunities for Mifepristone 25mg Tablet in the PCD pharma franchise market?

Mifepristone 25mg Tablet has demand in the gynecology, reproductive health, and specialty healthcare segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on women's healthcare portfolios.

Why should medical distributors include Mifepristone 25mg Tablet in their product range?

Medical distributors and agencies can benefit from consistent demand for specialized gynecological treatment under qualified medical supervision. Mifepristone 25mg is a progesterone receptor antagonist that is used for specific gynecological indications as determined by the treating physician Depending on the approved indication and local prescribing guidelines, it may be prescribed for the medical management of symptomatic uterine fibroids or other approved gynecological conditions under specialist supervision Helps improve symptoms such as heavy menstrual bleeding and fibroid-related discomfort in appropriately selected patients, as advised by a gynecologist Oral tablet formulation offers convenient administration, with the dosage and duration individualized according to the patient's clinical condition and approved indication This medicine should be used only under the supervision of a qualified gynecologist. It is contraindicated during pregnancy except when used for approved medical indications under appropriate medical protocols. Patients require careful clinical assessment, counseling, and follow-up throughout treatment Frequently utilized in gynecology clinics, women's health centers, specialty hospitals, and tertiary care institutions Widely prescribed by gynecologists and obstetricians for approved therapeutic indications This strengthens a comprehensive women's healthcare and gynecology portfolio.

Does Cafoli LifeCare Pvt Ltd offer PCD pharma franchise opportunities for this product?

Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Mifepristone 25mg Tablet with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers.

What benefits do wholesalers get by partnering for this product?

Wholesalers and medical agencies benefit from consistent specialty prescription demand, expanding women's healthcare market opportunities, reliable supply chain support, institutional procurement opportunities, and attractive margins in the gynecology segment.

How can I become a distributor or franchise partner for this product?

Interested distributors, stockists, wholesalers, and institutional suppliers can partner with Cafoli LifeCare Pvt Ltd to access lucrative PCD pharma franchise opportunities across India. With exclusive monopoly rights, extensive promotional support, high-quality women's healthcare products, attractive business margins, and dependable logistics support, Cafoli LifeCare Pvt Ltd helps franchise partners build a successful and profitable pharmaceutical business.